BACKGROUND: High dead-space syringes (HDSS) are believed to confer an elevated risk of acquiring HIV and other blood-borne infections. OBJECTIVES: We identified prevalence and correlates of HDSS use among injection drug users (IDU) in Tijuana, Mexico, where syringe purchase and possession is legal without a prescription. METHODS: Beginning in 2011, IDU who reported being 18 years or older and injected drugs within the last month were recruited into a prospective study. At baseline and semi-annually, 557 IDU underwent HIV-testing and interviewer-administered surveys. Logistic regression was used to identify correlates of using HDSS. RESULTS: Of 557 IDU, 40% had ever used HDSS, mostly because no other syringe type was available (72%), or because they were easier to get (20%). Controlling for sex and age at first injection, use of HDSS was associated with cocaine as the first drug injected (Adjusted Odds Ratio [AOR]: 2.68; Confidence Interval 95% [CI]: 1.15-6.22), having been stopped or arrested by police (AOR: 1.84; 95% CI: 1.11-3.07), being deported from the US (AOR: 1.64; 95% CI:1.06-2.53), and believing it is illegal to carry syringes (AOR:1.78; 95% CI: 1.01-3.15). CONCLUSION: Use of HDSS is surprisingly common among IDU in Tijuana. Efforts are needed to expand coverage of low-dead space syringes through existing syringe exchange programs. Education is required to increase awareness of the harms associated with HDSS, and to inform IDU that syringe possession is legal across Mexico.
BACKGROUND: High dead-space syringes (HDSS) are believed to confer an elevated risk of acquiring HIV and other blood-borne infections. OBJECTIVES: We identified prevalence and correlates of HDSS use among injection drug users (IDU) in Tijuana, Mexico, where syringe purchase and possession is legal without a prescription. METHODS: Beginning in 2011, IDU who reported being 18 years or older and injected drugs within the last month were recruited into a prospective study. At baseline and semi-annually, 557 IDU underwent HIV-testing and interviewer-administered surveys. Logistic regression was used to identify correlates of using HDSS. RESULTS: Of 557 IDU, 40% had ever used HDSS, mostly because no other syringe type was available (72%), or because they were easier to get (20%). Controlling for sex and age at first injection, use of HDSS was associated with cocaine as the first drug injected (Adjusted Odds Ratio [AOR]: 2.68; Confidence Interval 95% [CI]: 1.15-6.22), having been stopped or arrested by police (AOR: 1.84; 95% CI: 1.11-3.07), being deported from the US (AOR: 1.64; 95% CI:1.06-2.53), and believing it is illegal to carry syringes (AOR:1.78; 95% CI: 1.01-3.15). CONCLUSION: Use of HDSS is surprisingly common among IDU in Tijuana. Efforts are needed to expand coverage of low-dead space syringes through existing syringe exchange programs. Education is required to increase awareness of the harms associated with HDSS, and to inform IDU that syringe possession is legal across Mexico.
Entities:
Keywords:
HIV; High dead-space syringes; Mexico; injection drug use; people who inject drugs
Authors: Jesus Bucardo; Kimberly C Brouwer; Carlos Magis-Rodríguez; Rebeca Ramos; Miguel Fraga; Saida G Perez; Thomas L Patterson; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2005-04-01 Impact factor: 4.492
Authors: Miguel Pinedo; José Luis Burgos; Angela M Robertson; Alicia Vera; Remedios Lozada; Victoria D Ojeda Journal: Glob Public Health Date: 2014-03-21
Authors: Angela M Robertson; Remedios Lozada; Alicia Vera; Lawrence A Palinkas; José Luis Burgos; Carlos Magis-Rodriguez; Gudelia Rangel; Victoria D Ojeda Journal: Qual Health Res Date: 2011-09-13
Authors: Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee Journal: AIDS Behav Date: 2010-06
Authors: Robin A Pollini; Jorge Alvelais; Manuel Gallardo; Alicia Vera; Remedios Lozada; Carlos Magis-Rodriquez; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2009-04-21 Impact factor: 4.492
Authors: Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: Claudia Rafful; Jason Melo; María Elena Medina-Mora; Gudelia Rangel; Xiaoying Sun; Sonia Jain; Dan Werb Journal: Drug Alcohol Rev Date: 2017-11-22
Authors: Adam Trickey; Margaret T May; Vivian Hope; Zoe Ward; Monica Desai; Ellen Heinsbroek; Matthew Hickman; Peter Vickerman Journal: Drug Alcohol Depend Date: 2018-09-15 Impact factor: 4.492
Authors: Joanna M Kesten; Rachel Ayres; Jane Neale; Jody Clark; Peter Vickerman; Matthew Hickman; Sabi Redwood Journal: Int J Drug Policy Date: 2016-10-24
Authors: Jose Luis Burgos; Javier A Cepeda; James G Kahn; Maria Luisa Mittal; Emilio Meza; Raúl Rafael Palacios Lazos; Psyché Calderón Vargas; Peter Vickerman; Steffanie A Strathdee; Natasha K Martin Journal: Harm Reduct J Date: 2018-05-23
Authors: Mario Morales; Claudia Rafful; Tommi L Gaines; Javier A Cepeda; Daniela Abramovitz; Irina Artamonova; Pieter Baker; Erika Clairgue; Maria Luisa Mittal; Teresita Rocha-Jimenez; Jaime Arredondo; Thomas Kerr; Arnulfo Bañuelos; Steffanie A Strathdee; Leo Beletsky Journal: BMC Int Health Hum Rights Date: 2018-09-15
Authors: Steffanie A Strathdee; Jaime Arredondo; Teresita Rocha; Daniela Abramovitz; Maria Luisa Rolon; Efrain Patiño Mandujano; Maria Gudelia Rangel; Horcasitas Omar Olivarria; Tommi Gaines; Thomas L Patterson; Leo Beletsky Journal: BMJ Open Date: 2015-08-10 Impact factor: 2.692